University of Michigan Rogel Cancer Center - Cancer Immunology and Immunotherapy Program ^Hubs

The Cancer Immunology and Immunotherapy Program at the University of Michigan Rogel Cancer Center is committed to advancing cancer immunotherapy research, with a specific emphasis on cancer vaccines. Their team of scientists and clinicians conducts research to understand the interactions between the immune system and cancer cells and develops innovative vaccine strategies to enhance anti-tumor immune responses. Through their clinical trials and collaborations, they aim to translate their findings into improved treatments for cancer patients.